细菌感染诱发乙型肝炎肝硬化患者发生肝性脑病60例回顾性研究

doi:10.3969/j.issn.1672-5069.2017.03.028

Abstract

Hua Xingping, Zhu Weigang, Liu Mingshui. A retrospective study of 60 hepatic encephalopathy induced by bacterial infection in patients with hepatitis B cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 358-359.

References

[1] 刁云辉,薛萌,沙金平,等. 细菌感染诱发肝性脑病乙型肝炎肝硬化临床特点研究. 中华医院感染学杂志,2016,26(6):1276-1278.
[2] 刘华,韩涛,李莹. 乙型肝炎肝硬化患者细菌感染诱发肝性脑病临床特点分析. 山东医药,2015,55(19):8-10.
[3] 科技部十二五重大专项联合课题组. 乙型肝炎病毒相关性肝硬化的临床诊断、评估和抗病毒治疗的综合管理. 中华消化杂志,2014,34(2):77-84.
[4] 中华医学会消化病学分会,中华医学会肝病学分会. 中国肝性脑病诊治共识意见(2013年,重庆). 中华消化杂志,2013,33(9):581-592.
[5] 郑金莲,胡操寒,潘华将,等. 乙型肝炎肝硬化患者细菌感染诱发肝性脑病的临床治疗效果分析. 中华医院感染学杂志,2016,26(4):742-754.
[6] 林占洲,谭斌,周华坚,等. 拉米夫定联合阿德福韦酯与恩替卡韦单药治疗乙型肝炎肝硬化48周疗效对比研究. 临床合理用药杂志,2011,4(9):10-11.
[7] 周祖模,陈林,金志刚,等. 拉米夫定应答不佳慢性乙型肝炎患者加用阿德福韦酯与换用恩替卡韦疗效比较. 中华临床感染病杂志,2012,5(6):328-331.
[8] Yeh ML,Huang CF,Hsieh MY,et al.Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification. J Clin Virol,2014,60(3):206-214.
[9] 郑强,刘世平,贾家猛,等. 联合检测血氨与血清色氨酸在急诊肝性脑病患者中的临床应用. 川北医学院学报,2016,31(4):506-512.
[10] 王鲁文,陈辉,樊骋, 等. 乙型肝炎肝硬化并发细菌感染患者外周血调节性T细胞动态变化及临床意义. 中华临床感染病杂志,2012,5(3):149-152.
[11] 李晨,王慧芬,胡瑾华, 等. 乙型肝炎病毒相关慢加急性肝衰竭患者外周血调节性T细胞、血清白细胞介素-6表达及动态变化的研究. 中华临床医师杂志(电子版),2012,6(20):32-36.
[12] 刘肄辉,张永华,刘莉,等. 辅助性T淋巴细胞9/调节性T淋巴细胞平衡在乙型肝炎病毒感染炎性反应中的变化及其意义. 中华传染病杂志,2013,31(11):646-649.
[13] 吕红,潘宗琴,胡世芸,等. CD4+CD25+Treg细胞和Th17细胞及白细胞介6与HBV相关慢加急性肝衰竭预后关系的Meta分析. 中华肝脏病杂志,2014,22(7):493-498.
[14] 陈邦涛,冯旭娇,宋少娟,等. 恩替卡韦与拉米夫定联合阿德福韦酯治疗乙型肝炎肝硬化失代偿期患者48周疗效Meta分析. 实用肝脏病杂志,2016,19(3):305-309.
[15] 李晓波,苏杨,蔺咏梅,等. 巨噬细胞炎性蛋白-1β与降钙素原在肝硬化自发细菌性腹膜炎诊断中的作用. 国际检验医学杂志,2016,9(3):308-310.
[16] 郝虎,陈明锴,丁泠文. 益生菌联合复方谷氨酰胺预防肝硬化失代偿期患者发生自发性细菌性腹膜炎的临床疗效研究. 医学研究杂志,2014,43(11):25-28.

A retrospective study of 60 hepatic encephalopathy induced by bacterial infection in patients with hepatitis B cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[6]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[7]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[8]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[11]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[12]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[13]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[14]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[15]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.